vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

RMR GROUP INC. is the larger business by last-quarter revenue ($66.7M vs $49.9M, roughly 1.3× MARAVAI LIFESCIENCES HOLDINGS, INC.). RMR GROUP INC. runs the higher net margin — 18.3% vs -71.6%, a 89.8% gap on every dollar of revenue. On growth, RMR GROUP INC. posted the faster year-over-year revenue change (40.8% vs -11.8%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

MRVI vs RMR — Head-to-Head

Bigger by revenue
RMR
RMR
1.3× larger
RMR
$66.7M
$49.9M
MRVI
Growing faster (revenue YoY)
RMR
RMR
+52.6% gap
RMR
40.8%
-11.8%
MRVI
Higher net margin
RMR
RMR
89.8% more per $
RMR
18.3%
-71.6%
MRVI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MRVI
MRVI
RMR
RMR
Revenue
$49.9M
$66.7M
Net Profit
$-35.7M
$12.2M
Gross Margin
25.8%
Operating Margin
-117.9%
48.1%
Net Margin
-71.6%
18.3%
Revenue YoY
-11.8%
40.8%
Net Profit YoY
-37.7%
91.1%
EPS (diluted)
$-0.24
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
RMR
RMR
Q4 25
$49.9M
$66.7M
Q3 25
$41.6M
Q2 25
$47.4M
Q1 25
$46.9M
Q4 24
$56.6M
Q3 24
$69.0M
Q2 24
$69.4M
Q1 24
$64.2M
Net Profit
MRVI
MRVI
RMR
RMR
Q4 25
$-35.7M
$12.2M
Q3 25
$-25.6M
Q2 25
$-39.6M
Q1 25
$-29.9M
Q4 24
$-25.9M
Q3 24
$-97.1M
Q2 24
$-9.8M
Q1 24
$-12.1M
Gross Margin
MRVI
MRVI
RMR
RMR
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
MRVI
MRVI
RMR
RMR
Q4 25
-117.9%
48.1%
Q3 25
-98.6%
Q2 25
-139.8%
Q1 25
-104.9%
Q4 24
-66.7%
Q3 24
-239.9%
Q2 24
-19.4%
Q1 24
-29.4%
Net Margin
MRVI
MRVI
RMR
RMR
Q4 25
-71.6%
18.3%
Q3 25
-61.4%
Q2 25
-83.5%
Q1 25
-63.9%
Q4 24
-45.8%
Q3 24
-140.6%
Q2 24
-14.1%
Q1 24
-18.8%
EPS (diluted)
MRVI
MRVI
RMR
RMR
Q4 25
$-0.24
$0.71
Q3 25
$-0.18
Q2 25
$-0.27
Q1 25
$-0.21
Q4 24
$-0.21
Q3 24
$-0.68
Q2 24
$-0.07
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$216.9M
$49.3M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$232.7M
Total Assets
$770.6M
$687.1M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
RMR
RMR
Q4 25
$216.9M
$49.3M
Q3 25
$243.6M
Q2 25
$269.9M
Q1 25
$285.1M
Q4 24
$322.4M
Q3 24
$578.2M
Q2 24
$573.2M
Q1 24
$561.7M
Total Debt
MRVI
MRVI
RMR
RMR
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
RMR
RMR
Q4 25
$212.4M
$232.7M
Q3 25
$245.4M
Q2 25
$265.9M
Q1 25
$300.6M
Q4 24
$325.3M
Q3 24
$344.9M
Q2 24
$434.7M
Q1 24
$410.7M
Total Assets
MRVI
MRVI
RMR
RMR
Q4 25
$770.6M
$687.1M
Q3 25
$849.2M
Q2 25
$897.0M
Q1 25
$959.8M
Q4 24
$1.0B
Q3 24
$1.3B
Q2 24
$1.4B
Q1 24
$1.4B
Debt / Equity
MRVI
MRVI
RMR
RMR
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
RMR
RMR
Operating Cash FlowLast quarter
$-22.8M
$10.7M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
RMR
RMR
Q4 25
$-22.8M
$10.7M
Q3 25
$-15.2M
Q2 25
$-10.3M
Q1 25
$-9.4M
Q4 24
$-14.6M
Q3 24
$13.1M
Q2 24
$17.4M
Q1 24
$-8.5M
Free Cash Flow
MRVI
MRVI
RMR
RMR
Q4 25
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$-20.5M
Q3 24
$4.5M
Q2 24
$7.9M
Q1 24
$-14.1M
FCF Margin
MRVI
MRVI
RMR
RMR
Q4 25
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
-36.2%
Q3 24
6.6%
Q2 24
11.4%
Q1 24
-22.0%
Capex Intensity
MRVI
MRVI
RMR
RMR
Q4 25
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
10.3%
Q3 24
12.4%
Q2 24
13.8%
Q1 24
8.8%
Cash Conversion
MRVI
MRVI
RMR
RMR
Q4 25
0.88×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons